product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IGFBP-6 Protein, CF
catalog :
876-B6-025
quantity :
25 ug
price :
407 USD
more info or order :
citations: 5
Reference
Chen Q, Qin S, Liu Y, Hong M, Qian C, Keller E, et al. IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker. Oncotarget. 2016;7:68140-68150 pubmed publisher
Zhu W, Wu Y, Cui C, Zhao H, Ba J, Chen H, et al. Expression of IGFBP‑6 in proliferative vitreoretinopathy rat models and its effects on retinal pigment epithelial‑J cells. Mol Med Rep. 2014;9:33-8 pubmed publisher
Barkho B, Song H, Aimone J, Smrt R, Kuwabara T, Nakashima K, et al. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells Dev. 2006;15:407-21 pubmed
Cortesio C, Jiang W. Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein 5. Arch Biochem Biophys. 2006;449:164-70 pubmed
Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, et al. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem Biophys Res Commun. 2005;333:1011-6 pubmed
product information
brand :
R&D Systems
master code :
876-B6
SKU :
876-B6-025
product name :
Recombinant Human IGFBP-6 Protein, CF
unit size :
25 ug
seo description :
The Recombinant Human IGFBP-6 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human IGFBP-6 Protein, CF has been validated for the following applications: Bioactivity.
target :
IGFBP-6
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in Acetonitrile and TFA.
conjugate :
Unconjugated
dilution :
Bioactivity
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
species :
Human
observed molecular weight :
34 kDa, reducing conditions
theoretical molecular weight :
23 kDa
gene symbol :
IGFBP6
details of functionality :
Measured by its ability to inhibit the biological activity of IGF-I or IGF-II on MCF-7 human breast cancer cells. Karey, K.P. et al . (1988) Cancer Research 48 :4083. The ED50 for this effect is 0.025-0.15 ╡g/mL in the presence of 14 ng/mL Recombinant Human IGF-II (Catalog # 292-G2 ).
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
NP_002169
applications :
Bioactivity
source :
NS0-derived Recombinant Human IGFBP-6 Protein, CF
USD :
407 USD
alt names :
IBP6, IBP-6, IGF binding protein 6, IGF-binding protein 6, IGFBP6, IGFBP-6, insulin-like growth factor binding protein 6, insulin-like growth factor-binding protein 6
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, <= -20 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, <= -20 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.